These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4941227)

  • 41. The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats.
    Uechi M; Matsuoka M; Kuwajima E; Kaneko T; Yamashita K; Fukushima U; Ishikawa Y
    J Vet Med Sci; 2003 Oct; 65(10):1057-61. PubMed ID: 14600341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Kidney excretory function and the effect of furosemide following the chronic use of captopril in rats].
    Pir'ova B; Nachev N; Gŭrchev R
    Eksp Med Morfol; 1985; 24(2):13-20. PubMed ID: 3905355
    [No Abstract]   [Full Text] [Related]  

  • 43. Cooperative mechanisms involved in chronic antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Karimi Z
    Acta Physiol Hung; 2014 Mar; 101(1):88-102. PubMed ID: 24631797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diuresis and diuretics].
    Schmidt P
    Wien Klin Wochenschr; 1971 Jun; 83(25):456-9. PubMed ID: 5130897
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of chlortenoxicam and indomethacin on frusemide-induced diuresis.
    Hitoglou-Makedou A; Lawson M; Turner P; Ferber HP
    Postgrad Med J; 1989 Nov; 65(769):821-3. PubMed ID: 2694142
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Captopril-furosemide survival study in experimental heart failure.
    Mougenot N; Bos R; Médiani O; Lechat P
    Fundam Clin Pharmacol; 2005 Aug; 19(4):457-64. PubMed ID: 16011733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bioequivalence between two furosemide-spironolactone formulations: a pharmacokinetic and pharmacodynamic approach.
    Schütz W; Freissmuth M; Tuisl E; Blöchl-Daum B; Eichler HG; Loew D
    Curr Med Res Opin; 1991; 12(7):450-8. PubMed ID: 1778087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TREATMENT OF ARTERIAL HYPERTENSIVE DISEASE WITH DIURETICS. III. CHLORTHALIDONE ALONE AND IN COMBINATION WITH SPIRONOLACTONE.
    JOHNSTON LC; GRIEBLE HG; SCHOENBERGER JA; FULLER JB
    Am J Med Sci; 1964 Feb; 247():164-74. PubMed ID: 14124705
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cooperative mechanisms of acute antidiuretic response to bendroflumethiazide in rats with lithium-induced nephrogenic diabetes insipidus.
    Moosavi SM; Haghani M
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1191-201. PubMed ID: 21164566
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J; Abraham WT; Dürr JA; Schrier RW
    Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the sites of action of ethacrynic acid and furosemide during angiotensin infusion.
    Rado JP; Szende L; Tako J; Borbely L
    J Clin Pharmacol J New Drugs; 1970; 10(6):375-81. PubMed ID: 4320100
    [No Abstract]   [Full Text] [Related]  

  • 55. The treatment of non-digitalized congestive heart failure patients with a fixed-dose combination of furosemide and spironolactone.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):480-5. PubMed ID: 3714756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of furosemide on water and sodium excretion in apparently normal infants].
    López Uriarte A; Sánchez Burgos J; Santos Atherton D
    Bol Med Hosp Infant Mex; 1976; 33(3):693-8. PubMed ID: 1275971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction.
    Dikshit K; Vyden JK; Forrester JS; Chatterjee K; Prakash R; Swan HJ
    N Engl J Med; 1973 May; 288(21):1087-90. PubMed ID: 4697939
    [No Abstract]   [Full Text] [Related]  

  • 58. Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters.
    Lambert C; Larose P; Ong H; Gutkowska J; du Souich P
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):181-99. PubMed ID: 3909271
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: mechanistic evidence to support RALES.
    Bauersachs J; Fraccarollo D; Ertl G; Gretz N; Wehling M; Christ M
    Circulation; 2000 Nov; 102(19):2325-8. PubMed ID: 11067783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diuretic effect of butoxymethylen furosemide (FFBU) in healthy subjects: a preliminary study.
    Licht A; Levy M; Schindel L; Eliakim M
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):713-26. PubMed ID: 4201316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.